Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Solid-Phase PEGylation of Recombinant Interferon alpha-2a for Site-Specific Modification: Process Performance, Characterization, and in Vitro Bioactivity.

Solid-Phase PEGylation of Recombinant Interferon alpha-2a for Site-Specific Modification: Process Performance, Characterization, and in Vitro Bioactivity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Solid-Phase PEGylation of Recombinant Interferon alpha-2a for Site-Specific Modification: Process Performance, Characterization, and in Vitro Bioactivity. Abstract Text:

    byung kook leeByung Kook Lee,jin sook kwonJin Sook Kwon,hyung jin kimHyung Jin Kim,shuichi yamamotoShuichi Yamamoto,e k leeE K Lee,byung kook leeByung Kook Lee,jin sook kwonJin Sook Kwon,hyung jin kimHyung Jin Kim,shuichi yamamotoShuichi Yamamoto,e k leeE K Lee,byung kook leeByung Kook Lee,jin sook kwonJin Sook Kwon,hyung jin kimHyung Jin Kim,shuichi yamamotoShuichi Yamamoto,e k leeE K Lee,

    'Solid-phase' PEGylation, in which a conjugation reaction attaches proteins to a solid matrix, has distinct advantages over the conventional, solution-phase process. We report a case study in which recombinant interferon (rhIFN) alpha-2a was adsorbed to a cation-exchange resin and PEGylated at the N-terminus by 5, 10, and 20 kDa mPEG aldehydes through reductive alkylation. After PEGylation, a salt gradient elution efficiently purified the mono-PEGylate of unwanted species such as unmodified IFN and unreacted PEG. Mono-PEGylation and purification were integrated into a single, chromatographic step. Depending on the molecular weight of the mPEG aldehyde, the mono-PEGylation yield ranged from 50 to 65%. Major problems associated with the solution-phase process such as random or uncontrollable multi-PEGylation and post-PEGylation purification difficulties were overcome. N-terminus sequencing and MALDI-TOF mass spectrophometry confirmed that the PEG molecule was conjugated only to the N-terminus. A cell proliferation study indicated reduced antiviral activity of the mono-PEGylate compared to that of the unmodified IFN. As higher molecular weight PEG was conjugated, in vitro bioactivity and antibody binding activity, as measured by a surface plasmon resonance biosensor, decreased. Nevertheless, trypsin resistance and thermal stability were considerably improved .

    Solid-Phase PEGylation of Recombinant Interferon alpha-2a for Site-Specific Modification: Process Performance, Characterization, and in Vitro Bioactivity. Publishing Authors By Initials

    bk leeBK Lee,js kwonJS Kwon,hj kimHJ Kim,s yamamotoS Yamamoto,ek leeEK Lee,bk leeBK Lee,js kwonJS Kwon,hj kimHJ Kim,s yamamotoS Yamamoto,ek leeEK Lee,bk leeBK Lee,js kwonJS Kwon,hj kimHJ Kim,s yamamotoS Yamamoto,ek leeEK Lee,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Solid-Phase PEGylation of Recombinant Interferon alpha-2a for Site-Specific Modification: Process Performance, Characterization, and in Vitro Bioactivity. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Bioconjugate chemistry

    VOLUME: 18

    Page Numbers: 1728-34

    Journal Abbreviation: Bioconjug. Chem.

    ISSN: 1043-1802

    DAY: 18

    MONTH: 10

    YEAR: 2007

    Solid-Phase PEGylation of Recombinant Interferon alpha-2a for Site-Specific Modification: Process Performance, Characterization, and in Vitro Bioactivity. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9010319

    Solid-Phase PEGylation of Recombinant Interferon alpha-2a for Site-Specific Modification: Process Performance, Characterization, and in Vitro Bioactivity. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Solid-Phase PEGylation of Recombinant Interferon alpha-2a for Site-Specific Modification: Process Performance, Characterization, and in Vitro Bioactivity. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Solid-Phase PEGylation of Recombinant Interferon alpha-2a for Site-Specific Modification: Process Performance, Characterization, and in Vitro Bioactivity.

    AFFILIATION: eklee@hanyang.ac.kr.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Bioconjug Chem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Solid-Phase PEGylation of Recombinant Interferon alpha-2a for Site-Specific Modification: Process Performance, Characterization, and in Vitro Bioactivity Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News